Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-14 4:05 pm Unchanged | 2025-04-11 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 485,689 26.800% | 0 (Unchanged) | Filing History |
| 2025-04-10 4:05 pm Purchase | 2025-03-31 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 485,689 44.300% | 485,689 (New Position) | Filing History |
| 2024-08-14 4:40 pm Purchase | 2024-08-13 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 473,503 45.800% | 473,503 (New Position) | Filing History |
| 2024-02-28 4:07 pm Unchanged | 2024-02-27 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 419,114 46.700% | 0 (Unchanged) | Filing History |
| 2024-01-22 4:26 pm Purchase | 2024-01-18 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 419,114 50.900% | 20,957 (+5.26%) | Filing History |
| 2023-12-08 5:28 pm Sale | 2023-12-04 | 13D | EyePoint Pharmaceuticals, Inc. EYPT | EW Healthcare Partners L.P. | 2,337,786 5.000% | -1,312,606 (-35.96%) | Filing History |
| 2023-10-23 4:05 pm Purchase | 2023-10-20 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 398,157 44.200% | 51,073 (+14.71%) | Filing History |
| 2023-09-14 6:36 pm Sale | 2023-09-08 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 347,084 44.200% | -61,625 (-15.08%) | Filing History |
| 2023-08-30 5:22 pm Sale | 2019-03-28 | 13D | EyePoint Pharmaceuticals, Inc. EYPT | EW Healthcare Partners L.P. | 3,650,392 10.400% | -540,004 (-12.89%) | Filing History |
| 2023-07-14 3:23 pm Purchase | 2023-07-12 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 408,710 50.700% | 121,270 (+42.19%) | Filing History |
| 2023-05-24 1:22 pm Purchase | 2023-05-15 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 287,439 42.000% | 68,155 (+31.08%) | Filing History |
| 2022-11-29 6:04 pm Unchanged | 2022-11-18 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 219,285 40.600% | 0 (Unchanged) | Filing History |
| 2022-11-28 5:17 pm Purchase | 2022-11-18 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 219,285 41.380% | 90,985 (+70.92%) | Filing History |
| 2022-02-03 4:09 pm Purchase | 2022-02-03 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 128,300 35.880% | 23,852 (+22.84%) | Filing History |
| 2021-02-12 4:36 pm Purchase | 2020-12-31 | 13D | Venus Concept Inc. VERO | EW Healthcare Partners L.P. | 104,447 29.520% | 24,587 (+30.79%) | Filing History |
| 2021-02-09 2:21 pm Sale | 2020-12-31 | 13G | AxoGen, Inc. AXGN | EW Healthcare Partners L.P. | 1,981,888 4.940% | -448,111 (-18.44%) | Filing History |